Switch to:
More From Other Websites
Eliquis and Sprycel Could Boost BMY’s Revenue Growth in 2H17 Aug 22 2017
What Sprycel Could Mean for Bristol-Myers Squibb Jul 10 2017
​SEC charges two former Ariad executives with insider trading Jun 27 2017
Analyzing Incyte’s Revenue Streams in 1Q17 Jun 15 2017
Former Ariad CEO joins a familiar face on board of The Medicines Co., hinting at a sale Apr 06 2017
Amgen's Blincyto sBLA Secures FDA Priority Review Mar 30 2017
Who Is Incyte Collaborating With? Mar 01 2017
Two Great Stock Ideas in the IBB Biotech ETF Feb 15 2017
ARIAD Files for EU Approval of Lung Cancer Drug Brigatinib Feb 07 2017
Why Ariad Pharmaceuticals Stock Nearly Doubled in January Feb 06 2017
Ariad Submits Marketing Application to EU Agency Feb 06 2017
ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European... Feb 06 2017
Blog Coverage Exelixis Partners with Takeda to Commercialize and Develop Novel Cancer Therapy... Feb 01 2017
Ariad mum on layoffs in letter to employees: ‘It’s business as usual’ Jan 25 2017
Ariad Put Off Potential Suitor Amid 'Aggressive' Takeda Bid: RBC Jan 20 2017
Ariad played hardball to boost Takeda buyout price, federal filings show Jan 20 2017
Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017 Jan 20 2017
Can The Uptrend Continue for ARIAD Pharmaceuticals (ARIA)? Jan 20 2017
5 Expensive Drugs That Could End Up in Trump's Crosshairs Jan 18 2017
Ariad Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of ARIA Shareholders Jan 18 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK